{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T18:48:29Z","timestamp":1780512509646,"version":"3.54.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.vaccine.2025.126903","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T16:36:36Z","timestamp":1740242196000},"page":"126903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration into routine immunization services in Cuba"],"prefix":"10.1016","volume":"52","author":[{"given":"Sonia","family":"Resik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Lopez Cavestany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Tejeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilda","family":"Alema\u00f1y","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ileana","family":"Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marila","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magil\u00e9","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai Heng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaray","family":"M\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danay","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.126903_bb0005","series-title":"Handbook of resolutions and decisions of the world health assembly and the executive board, volume III, 3rd edition (1985\u20131992)","first-page":"1993","article-title":"Resolution WHA. 41.28. Global eradication of poliomyelitis by the year","author":"WHO","year":"2000"},{"key":"10.1016\/j.vaccine.2025.126903_bb0010","author":"WHO"},{"key":"10.1016\/j.vaccine.2025.126903_bb0015","author":"WHO"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2025.126903_bb0020","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/infdis\/jix038","article-title":"Intradermal administration of fractional doses of inactivated poliovirus vaccine: a dose-sparing option for polio immunization","volume":"216","author":"Okayasu","year":"2017","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2025.126903_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule","volume":"35","author":"Anand","year":"2017","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2025.126903_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2025.126903_bb0035","doi-asserted-by":"crossref","first-page":"6816","DOI":"10.1016\/j.vaccine.2015.09.039","article-title":"Early priming with inactivated poliovirus vaccine (IPV) and intradermal fractional dose IPV administered by a microneedle device: a randomized controlled trial","volume":"33","author":"Anand","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126903_bb0040","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2025.126903_bb0045","article-title":"Immunogenicity of intramuscular fractional dose of inactivated poliovirus vaccine","volume":"221","author":"Resik","year":"2020","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126903_bb0050","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S1473-3099(20)30693-9","article-title":"Fractional dose compared with standard dose inactivated poliovirus vaccine in children: a systematic review and meta-analysis - the lancet infectious diseases","volume":"21","author":"Mashunye","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2025.126903_bb0055","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.126903_bb0065","author":"PharmaJet: Tropis\u00ae ID"},{"issue":"1","key":"10.1016\/j.vaccine.2025.126903_bb0070","first-page":"1","article-title":"An experience of mass administration of fractional dose inactivated polio vaccine through intradermal needle-free injectors in Karachi, Sindh","volume":"21","author":"Bullo","year":"2021","journal-title":"Pak BMC Public Health"},{"issue":"8","key":"10.1016\/j.vaccine.2025.126903_bb0075","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.vaccine.2019.12.059","article-title":"Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: a survey of caregiver and vaccinator acceptability","volume":"38","author":"Daly","year":"2020","journal-title":"Vaccine"},{"issue":"47","key":"10.1016\/j.vaccine.2025.126903_bb0080","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.15585\/mmwr.mm7247a3","article-title":"Notes from the field: house-to-house campaign administration of Inactivated Poliovirus Vaccine \u2014 Sokoto state, Nigeria, november 2022","volume":"72","author":"Biya","year":"2023","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.126903_bb0085","series-title":"Development agency and health-focused consortium launch assessment of the pharmajet tropis vaccine delivery system","author":"Nigeria's National Primary Health Care","year":"2023"},{"key":"10.1016\/j.vaccine.2025.126903_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2025.126903_bb0095","article-title":"Achieving high immunogenicity against poliovirus with fractional doses of inactivated poliovirus vaccine in Ecuador-results from a cross-sectional serological survey","volume":"11","author":"Trueba","year":"2022","journal-title":"Lancet Reg Health Am"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25002002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T14:30:34Z","timestamp":1750861834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25002002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"alternative-id":["S0264410X25002002"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126903","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tropis needle-free injector for fractional-dose IPV administration: A pilot study for integration into routine immunization services in Cuba","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.126903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126903"}}